GST rate amendment revises product classifications for medicines, snack items and seating entries under the Uttarakhand tax schedule. Uttarakhand GST rate notification amends the existing schedule of goods under the State GST framework by inserting Trastuzumab Deruxtecan, Osimertinib and Durvalumab in Schedule I at 2.5%, adding extruded or expanded savoury or salted products in Schedule II at 6%, and revising Schedule III and IV entries for snack pellets and seats. The amendment is stated to be deemed effective from 10 October 2024.